{"disease":{"id":"schistosomiasis","name":"schistosomiasis"},"drugs":{"marketed":[{"drug_id":"cysticide","indication_name":"Schistosomiasis due to S. Haematobium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cysticide","company_name":"Merck KGaA, Darmstadt, Germany","drug_phase":"phase_1","molecular_target":"Bile salt export pump, Glutathione S-transferase class-mu 26 kDa isozyme, High voltage-activated calcium channel beta subunit CavB1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"cysticide","indication_name":"Schistosomiasis due to S. Japonicum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cysticide","company_name":"Merck KGaA, Darmstadt, Germany","drug_phase":"phase_1","molecular_target":"Bile salt export pump, Glutathione S-transferase class-mu 26 kDa isozyme, High voltage-activated calcium channel beta subunit CavB1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"cysticide","indication_name":"Schistosomiasis due to S. Mansoni","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cysticide","company_name":"Merck KGaA, Darmstadt, Germany","drug_phase":"phase_1","molecular_target":"Bile salt export pump, Glutathione S-transferase class-mu 26 kDa isozyme, High voltage-activated calcium channel beta subunit CavB1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"cysticide","indication_name":"Schistosomiasis due to S. Mekongi","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cysticide","company_name":"Merck KGaA, Darmstadt, Germany","drug_phase":"phase_1","molecular_target":"Bile salt export pump, Glutathione S-transferase class-mu 26 kDa isozyme, High voltage-activated calcium channel beta subunit CavB1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06560853","title":"Evaluation of a Comprehensive School Health Programme in Zambia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28700,"lead_sponsor_name":"London School of Economics and Political Science","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07500740","title":"Nanobody-based Schistosomiasis Urine Test Kit Research","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Pemba Ministry of Health Zanzibar","has_results":false},{"nct_id":"NCT07507461","title":"Protocol for Integrating Mass Drug Administration Into Primary Health Care in Western Kenya","phase":"NA","overall_status":"COMPLETED","enrollment_count":1229,"lead_sponsor_name":"Amref Health Africa","has_results":false},{"nct_id":"NCT06182176","title":"Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT03458338","title":"Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa","phase":"","overall_status":"COMPLETED","enrollment_count":1006,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05868005","title":"Delivering a Multi-disease Screening Tool to Migrant Populations","phase":"NA","overall_status":"COMPLETED","enrollment_count":980,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT06312462","title":"Health Education Model Led by Community Health Volunteers.","phase":"NA","overall_status":"COMPLETED","enrollment_count":978,"lead_sponsor_name":"Pemba Ministry of Health Zanzibar","has_results":true},{"nct_id":"NCT03640377","title":"Praziquantel in Children Under Age 4","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Rhode Island Hospital","has_results":false},{"nct_id":"NCT04810741","title":"Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France","phase":"","overall_status":"COMPLETED","enrollment_count":532,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02806232","title":"An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Merck KGaA, Darmstadt, Germany","has_results":true},{"nct_id":"NCT06973200","title":"Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Centre MURAZ/Institut National de Santé Publique","has_results":false},{"nct_id":"NCT03910972","title":"Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT03845140","title":"L-PZQ ODT in Schistosoma Infected Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Merck KGaA, Darmstadt, Germany","has_results":true},{"nct_id":"NCT04635553","title":"Monitoring Schistosome Hybrids Under Under Praziquantel Pressure","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Institut de Recherche pour le Developpement","has_results":false},{"nct_id":"NCT05350462","title":"Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study","phase":"","overall_status":"UNKNOWN","enrollment_count":225,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT05788003","title":"Female Genital Schistosomiasis in Tanzania","phase":"NA","overall_status":"UNKNOWN","enrollment_count":206,"lead_sponsor_name":"IRCCS Sacro Cuore Don Calabria di Negrar","has_results":false},{"nct_id":"NCT03870204","title":"Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum","phase":"","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Ina-Respond","has_results":false},{"nct_id":"NCT02868385","title":"Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT05658614","title":"Anti-Schistosomiasis Sm14-vaccine in Senegal","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Oswaldo Cruz Foundation","has_results":false},{"nct_id":"NCT03133832","title":"The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Jiangsu Institute of Parasitic Diseases","has_results":false},{"nct_id":"NCT05762393","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"International Vaccine Institute","has_results":false},{"nct_id":"NCT04115072","title":"Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Regionshospital Nordjylland","has_results":false},{"nct_id":"NCT03779347","title":"Schistosomiasis Diagnosis Using a CAA Antigen Test","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Centre de Recherche Médicale de Lambaréné","has_results":false},{"nct_id":"NCT03799510","title":"Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Oswaldo Cruz Foundation","has_results":false},{"nct_id":"NCT03158298","title":"Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas","phase":"","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Jena University Hospital","has_results":true},{"nct_id":"NCT02337855","title":"A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03110757","title":"A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04264130","title":"Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Centre de Recherche Médicale de Lambaréné","has_results":false},{"nct_id":"NCT06828536","title":"Female Genital Schistosomiasis in Migrant Women: A Pilot Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05292391","title":"Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03041766","title":"Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Oswaldo Cruz Foundation","has_results":false},{"nct_id":"NCT05085470","title":"Repeated Controlled Human Schistosoma Mansoni Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT04589390","title":"Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT02755324","title":"Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Leiden University","has_results":false},{"nct_id":"NCT04269915","title":"Single-sex Female Controlled Human Schistosomiasis Mansoni Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT02734186","title":"Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":38},"guidelines":[],"source":"Drug Landscape verified database"}